klh-2109
Showing 1 - 6 of 6
Uterine Fibroids (MeSH Heading: Leiomyoma) Trial (KLH-2109, Placebo)
Recruiting
- Uterine Fibroids (MeSH Heading: Leiomyoma)
- KLH-2109
- Placebo
-
Multiple Locations, JapanClinical Research Site
Nov 24, 2022
Uterine Fibroids (MeSH Heading: Leiomyoma) Trial (KLH-2109, Leuprorelin)
Not yet recruiting
- Uterine Fibroids (MeSH Heading: Leiomyoma)
- KLH-2109
- Leuprorelin
- (no location specified)
Jul 19, 2022
Endometriosis Trial in Multiple Locations (KLH-2109, Placebo, Leuprorelin acetate)
Completed
- Endometriosis
- KLH-2109
- +2 more
-
Multiple Locations, Japan(unnamed)
Jun 3, 2019
Endometriosis Trial in Tokyo and Other Japanese City (KLH-2109, )
Completed
- Endometriosis
- KLH-2109
- placebo
-
Tokyo and Other Japanese City, JapanJapan
May 29, 2014
Endometriosis Trial in Tokyo and Other Japanese City (KLH-2109)
Completed
- Endometriosis
- KLH-2109
-
Tokyo and Other Japanese City, JapanJapan
May 29, 2014
Endometriosis Trial in Tokyo and Other Japanese City (KLH-2109)
Completed
- Endometriosis
- KLH-2109
-
Tokyo and Other Japanese City, JapanJapan
Oct 29, 2013